News
- 2017.11.14 Society New published research paper: “Evidence-Based Review of BioBran/MGN-3 Arabinoxylan Compound as a Complementary Therapy for Conventional Cancer Treatment”
- 2017.11.14 Society New published research paper: “Can a standardized plant immunomodulator (rice bran arabinoxylan concentrate/MGN-3) increase the effects of MEK and BRAF inhibitors with clinical benefit? Case report of a patient with carcinoma in biliary duct”
- 2017.09.26 Society Academic Presentation: The 9th A4M Thailand Congress on Anti-Aging and Aesthetics Medicine
- 2017.09.26 Society NKCP International Workshop
- 2017.07.25 Society New Published Research Paper: Controlled pilot study for cancer patients suffering from chronic fatigue syndrome due to chemotherapy treated with BioBran (MGN-3 Arabinoxylane) and targeted radiofrequency heat therapy
- 2017.07.25 Society BioBran Workshop 2017 (DHD Europe)
- 2017.06.14 Society Training Session for a business partner in Canada (DHD USA)
- 2017.06.14 Society Training session for Daiwa’s business partners
- 2017.05.22 Society New Published Research Paper: Modified rice bran hemicellulose inhibits vascular endothelial growth factor-induced angiogenesis in vitro via VEGFR2 and its downstream signaling pathways
- 2017.03.07 Society New published research paper: Arabinoxylan rice bran (Biobran) suppresses the viremia level in patients with chronic HCV infection: A randomized trial
- 2017.02.17 Society Training Session for a business partner in the USA (DHD USA)
- 2017.01.24 Society New published research paper: From Bench to Bedside: The Growing Use of Arabinoxylan Rice Bran (MGN-3/Biobran) in Cancer Immunotherapy